Showing results (41-50 of 63) with videos related to
Sort By:
Pageof 7
Leukemia|January 20, 2024
Inherent genome instability underlies trisomy 21-associated myeloid malignanciesChun-Chin Chen, Rebecca E Silberman, Duanduan Ma, et al.Journal of Medicinal Chemistry|August 21, 2018
Structure-Guided Design and Development of Potent and Selective Dual Bromodomain 4 (BRD4)/Polo-like Kinase 1 (PLK1) InhibitorsShuai Liu, Hailemichael O Yosief, Lingling Dai, et al.Current Biology : CB|February 6, 2007
A role for Cdc2- and PP2A-mediated regulation of Emi2 in the maintenance of CSF arrestQiju Wu, Yanxiang Guo, Ayumi Yamada, et al.Genes & Development|June 19, 2008
Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human diseaseCarl R Walkley, Rameez Qudsi, Vijay G Sankaran, et al.Neuro-Oncology|November 5, 2014
Preclinical antitumor efficacy of selective exportin 1 inhibitors in glioblastomaAdam L Green, Shakti H Ramkissoon, Dilara McCauley, et al.Leukemia|January 8, 2026
Identifying targeted therapies for CBFA2T3::GLIS2 acute myeloid leukemiaFanny Gonzales, Constanze Schneider, Gabriela Alexe, et al.Nature Chemical Biology|March 28, 2018
The dTAG system for immediate and target-specific protein degradationBehnam Nabet, Justin M Roberts, Dennis L Buckley, et al.Nature Chemical Biology|March 7, 2018
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligandsLara N Gechijian, Dennis L Buckley, Matthew A Lawlor, et al.Cancer Discovery|April 11, 2022
Unleashing Cell-Intrinsic Inflammation as a Strategy to Kill AML BlastsJana M Ellegast, Gabriela Alexe, Amanda Hamze, et al.Cell|November 18, 2006
Role for the PP2A/B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosisSeth S Margolis, Jennifer A Perry, Craig M Forester, et al.Pageof 7